同益中(688722.SH):一季度淨利潤預計同比增加約153.27%
格隆匯4月8日丨同益中(688722.SH)公佈,經公司財務部門初步測算,預計2025年第一季度實現營業收入約2.53億元,同比增加約126.90%。預計2025年第一季度實現歸屬於母公司所有者的淨利潤約4,444.10萬元,同比增加約153.27%。預計2025年第一季度實現歸屬於母公司所有者的扣除非經常性損益的淨利潤約4,100.31萬元,同比增加約168.92%。
報吿期內,公司充分發揮自身在研發創新、生產工藝、產能佈局和精益化管理等方面的優勢,持續提升產品性能和產品競爭力,全力拓展市場份額。同時,公司併購超美斯帶來收入及利潤貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.